Timothy R Gershon

19PUBLICATIONS

86CO-AUTHORS

Molecular targetsGene and molecular therapyNeurology and neuromuscular diseasesRadiation therapyPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jun 04, 2026

Tumor Microenvironmental Regulation of CAR T-Cell Therapy in High Risk Medulloblastoma.

|Apr 17, 2026

Myeloid compartment reprogramming through nanoparticle-delivered resiquimod blocks paracrine growth support and activates phagocytosis to slow tumor progression in endogenous mouse medulloblastoma and diffuse midline glioma models.

|Mar 19, 2025

Reply to: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas.

Christopher L Moertel, Angela C Hirbe, Laura J Klesse

|Feb 05, 2025

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.

Yuchen Li, Chaemin Lim, Taylor Dismuke

|Nov 08, 2024

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber

|Jul 20, 2023

Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX.

Rumani Singh, Stacey Yu, Marwa Osman

Pageof 4

Frequent Collaborators

4 joint publications

Jessica Raper

4 joint publications

Marina Sokolsky-Papkov

4 joint publications

Benjamin R Babcock

4 joint publications

Alexander V Kabanov

3 joint publications

Jennifer Karin Ocasio

Kirk Wilhelmsen

Michael D Taylor

Christopher Lazarski

Olivier Saulnier

Elias P Rosen

Frequent Collaborators

4 joint publications

Jessica Raper

4 joint publications

Marina Sokolsky-Papkov

4 joint publications

Benjamin R Babcock

4 joint publications

Alexander V Kabanov